investorscraft@gmail.com

Intrinsic value of Nu Skin Enterprises, Inc. (NUS)

Previous Close$43.35
Intrinsic Value
Upside potential
Previous Close
$43.35

VALUATION INPUT DATA (original, your and others' valuations)

ParameterOrig.Your
Date of valuation (DoV)  
Intrinsic value (IV) at DoV, $/sh  
IV at current val. algorithm, $/sh80.76 

The original valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-03-31.

Registered users can save their valuation input data

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.

Company description

Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %4.4NaN
Revenue, $2696NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m2462NaN
Operating income, $m234NaN
EBITDA, $m359NaN
Interest expense (income), $mNaN
Earnings before tax, $m232NaN
Tax expense, $m85NaN
Net income, $m147NaN

BALANCE SHEET

Cash and short-term investments, $m355NaN
Total assets, $m1906NaN
Adjusted assets (=assets-cash), $m1551NaN
Average production assets, $m895NaN
Working capital, $m329NaN
Total debt, $m504NaN
Total liabilities, $m993NaN
Total equity, $m913NaN
Debt-to-equity ratio0.552NaN
Adjusted equity ratio0.451NaN

CASH FLOW

Net income, $m147NaN
Depreciation, amort., depletion, $m125NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m142NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-69NaN
Free cash flow, $m210NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m329
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount